Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date HER2-Low: a new category of patients who benefit from HER2-targeted therapy Dr. David Hicks, University of Rochester and Dr. Sunil Badve, Emory University In this webinar, Drs. Hicks and Badve will discuss the latest advances in HER2 immunohistochemical testing and interpretation, with a focus on the eme... 3 months ago | 53 mins Immunohistochemistry detection of DNA mismatch repair in colorectal cancer Dr. Weiqi Sheng, Fudan University Shanghai Cancer Center & Dr. Ying Kong, Roche Diagnostics Solutions This webinar, sponsored by Roche, aims to provide an understanding of the scientific development and significance of DNA mismatch repair (MMR) deficie... 1 year ago | 45 mins 固形がんにおけるDNAミスマッチ修復(MMR) 機能異常とその臨床的意義 〜IHC検査とがん免疫療法の臨床事例を踏まえて〜 Dr. Takeshi Kuwata and Dr. Akihito Kawazoe, both from National Cancer Center Hospital East, Chiba, Japan (Note: This webinar will be presented in Japanese.) In this webinar, our speakers will discuss mechanisms and clinical evaluation of DNA mismatch repa... 11 months ago | 62 mins Cost effectiveness analysis of PD-L1 testing in NSCLC - IVD vs LDT Jason Hurwitz, BA, MA, Phd; Shannon Vaffis, MPH, Phd; Amy Grizzle, BA, Pharm D This webinar will share compelling research that evaluated the cost-effectiveness of PD-L1 testing with an in vitro diagnostic (IVD) compared to a lab... 12 months ago | 45 mins Optimising patient selection for anti-EGFR therapy in metastatic CRC Dr. Chris Williams & Dr. Philip Quirke from Leeds Institute of Medical Research Division of Pathology and Data Analytics, UK In this webinar, Dr. Chris Williams, Clinical Research Fellow - Histopathology and Oncology and Dr. Philip Quirke, Professor of Pathology and Head of ... 2 years ago | 58 mins PathAI PD-L1(28-8)integration on Roche navify Digital Pathology open environment Eric Walk, MD, Chief Medical Officer, PathAI In this webinar, Dr. Walk will discuss how PathAI aims to improve cancer patient outcomes using the power of Artificial Intelligence, the importance o... 5 months ago | 60 mins Lung Cancer Diagnostics: Evolving Practice and Future Directions Professor Keith Kerr Personalized medicine for non-small-cell lung cancer (NSCLC) continues to evolve rapidly, building on a solid diagnostic foundation based on H&E and i... 3 years ago | 61 mins HER2 Testing: Towards a Brighter Future Dr. Sangeeta Desai, Dr. Suseela Kodandapani and Dr. Veena R This webinar, sponsored by Roche, provided valuable insights into the latest advances in HER2 diagnostics in breast cancer. Dr. Sangeeta Desai, Profes... 6 months ago | 76 mins Mismatch Repair Immunohistochemistry in Clinical Oncology Dr. Takeshi Kuwata and Dr. Akihito Kawazoe, both from National Cancer Center Hospital East, Chiba, Japan This webinar will discuss mechanisms and clinical evaluation of DNA mismatch repair (MMR) status in solid tumor oncology. Speakers will present case s... 1 year ago | 60 mins Designing Cytometry Assays for IO Applications: The Do's, Don'ts & Don't Forgets Dr. Tamara Laskowski, Senior Research Scientist of MD Anderson Cancer Center For many researchers flow cytometry can be overwhelming and confusing, especially if this is a technique is not used every day. In this webinar, Dr. ... 3 years ago | 61 mins Load more